Come contattare il centro
Centro HCP

come parte del Piano per le Malattie Rare 2006-2011, rietichettatura nel 2017. OPHTARA è
consorzio unico parte di ERN-EYE con 5 siti ospedalieri universitari di Parigi: Necker
(sito coordinatore), Pitié Salpetrière, HEGP, Cochin e Hôtel Dieu (siti componenti).
Immagine: Celette
Contatti
OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France
Team

Pr Dominique BREMOND-GIGNAC
Francia

Pr Alejandra Daruich-Matet
Francia

Pr Matthieu Robert
Francia
Test clinici

Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients From 6 Months to Less Than 2 Years Old

Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy

Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis (NEF-1)

Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.

A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.

A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

An International Prospective Natural History Study in Children With a Type II Collagen Disorder With Short Stature

Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy.

Long-Term Non-Interventional Latanoprost Study

Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.

Prospective Clinical Assessment Study in Children with Hypochondroplasia: ACCEL

An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis